TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 5 | 6 | 15 | 14 | 88 | 171 | 50 |
| P | %wins | 100 | 67 | 100 | 67 | 100 | 100 | 89 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/11/12 15:11 | 12/7/12 | ACRX | Acelrx Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Wan Mark A | CA | DT | P | 8,000 | 3.31 | 2 | 2,417 | 149 | 4,044 | I | 21 | 11 | 10 | 4 | -15 | -28 | -9 | 5 | 18 | 31 | 45 | 193 | 147 | ||
6/6/12 16:55 | 5/29/12 | ACRX | Acelrx Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Wan Mark A | CA | DT | P.ad | 968 | 3.40 | 0 | 285 | 4 | 7,950 | I | -33 | 11 | 7 | -1 | -13 | -8 | 7 | 0 | -4 | 3 | -5 | 17 | 176 | ||
5/31/12 16:23 | 5/29/12 | ACRX | Acelrx Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Wan Mark A | CA | DT | P.d | 968 | 3.40 | 0 | 285 | 4 | 7,950 | I | -36 | 5 | 9 | -10 | -17 | -15 | -12 | 10 | 5 | 11 | 1 | 54 | 189 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |